Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4d4b8874e0f6381aa860225585d5db9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee44d66df8d0652226f3af617d4901fb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-42 |
filingDate |
2003-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5572e2b363282c4c4ba8fd6b9cdfe491 |
publicationDate |
2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004052412-A1 |
titleOfInvention |
Wound dressings comprising vanadate complexed with organic ligands |
abstract |
The invention relates to wound dressings comprising a tyrosine phosphatase inhibitor that stimulates collagen deposition and fibroblast proliferation thereby accelerating wound healing. Preferred tyrosine phosphatase inhibitors are complexes of vanadate and peroxovanadate with organic ligands. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8008035-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8563263-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008178410-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1949894-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8278086-B2 |
priorityDate |
2002-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |